Cardi-OH

Research published in the The New England Journal of Medicine found that oral semaglutide 25 mg produced clinically meaningful weight‑loss efficacy in adults with obesity or overweight. In the OASIS 4 trial, participants lost an average of 13.6% of body weight at 64 weeks, offering a promising oral alternative to injectable GLP-1 therapies for chronic weight management. Learn more - https://bit.ly/4a3Kmxj.

Case Western Reserve University School of Medicine
University of Cincinnati College of Medicine
Northeast Ohio Medical University
Ohio University Heritage College of Osteopathic Medicine
Ohio State University College of Medicine
The University of Toledo College of Medicine and Life Sciences
Wright State University Boonshoft School of Medicine

The Cardi-OH team is out and about this week at Cleveland CME events! Today, we’re attending Cleveland Clinic Diabetes Day, and tomorrow we’ll be at the Obesity Summit. We look forward to connecting, learning, and sharing resources with healthcare professionals across the region. Stop by our table to say hello, pick up a Cardi-OH pen, and learn about our newly published resources.

Case Western Reserve University School of Medicine
University of Cincinnati College of Medicine
Northeast Ohio Medical University
Ohio University Heritage College of Osteopathic Medicine
Ohio State University College of Medicine
The University of Toledo College of Medicine and Life Sciences
Wright State University Boonshoft School of Medicine

How does heart health impact brain health? Listen to Alan J. Lerner, MD (Case Western Reserve University ) discuss the connection between cardiovascular health, cognitive function, and neurological well-being. Learn about shared risk factors—and practical strategies to support brain health across the lifespan. Listen now -> https://bit.ly/4w1xd1l



Case Western Reserve University School of Medicine
University of Cincinnati College of Medicine
Northeast Ohio Medical University
Ohio University Heritage College of Osteopathic Medicine
Ohio State University College of Medicine
The University of Toledo College of Medicine and Life Sciences
Wright State University Boonshoft School of Medicine

GLP-1 medications like semaglutide and tirzepatide are changing the way we treat obesity — but did you know they may also lead to a reduction in muscle mass? The right diet and physical activity strategies can help protectmuscle while losing weight. Click the link to learn more! https://bit.ly/3Q6T32W

Case Western Reserve University School of Medicine
University of Cincinnati College of Medicine
Northeast Ohio Medical University
Ohio University Heritage College of Osteopathic Medicine
Ohio State University College of Medicine
The University of Toledo College of Medicine and Life Sciences
Wright State University Boonshoft School of Medicine